What is Telfa (non-adherent dressing pad) used for in medical settings?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Telfa?

Telfa is a non-adherent wound dressing pad consisting of absorbent cotton fibers enclosed in a sleeve of thermoplastic polymers, designed to minimize adherence to wound surfaces while managing exudate and protecting healing tissue. 1, 2

Primary Composition and Design

  • Telfa dressings are constructed with absorbent cotton fibers encased in a thermoplastic polymer sleeve that creates a non-stick interface with the wound bed 2
  • Some formulations (Telfa AMD) incorporate polyhexamethylene biguanide (PHMB), an antimicrobial agent, though antimicrobial properties should not be the primary reason for selection 2
  • The non-adherent surface prevents the dressing from sticking to wounds during removal, reducing pain and trauma to healing tissue 2, 3

Clinical Applications and Indications

Telfa should be selected primarily based on exudate control, comfort, and cost rather than for accelerating wound healing or antimicrobial effects. 1, 4

Appropriate Uses:

  • Denuded dermis coverage in severe conditions like Stevens-Johnson syndrome/toxic epidermal necrolysis, where it serves as a non-adherent protective layer over exposed tissue 1
  • Split-thickness skin graft donor sites, where it provides comfortable wound coverage during re-epithelialization 2
  • Post-laser resurfacing wounds, particularly after CO2 laser treatment for wrinkles or acne scars 3
  • Routine sutured wounds when combined with topical antibiotic ointment for basic wound protection 5
  • Post-operative wound management in obstetric and gynecological surgeries 6

Clinical Performance Evidence

  • In donor-site wound management, Telfa AMD demonstrated significantly faster re-epithelialization (9.25 ± 1.88 days) compared to chlorhexidine-impregnated paraffin gauze (14.00 ± 3.05 days, p < 0.001) 2
  • Pain scores were markedly lower with Telfa AMD (1.57 ± 0.55) versus traditional paraffin dressings (4.70 ± 1.16, p < 0.001) 2
  • Cost-effectiveness was comparable between Telfa and traditional dressings, with no significant difference in treatment costs 2

Important Limitations and Caveats

Do not use Telfa or any dressing with the sole aim of accelerating healing of chronic ulcers, particularly diabetic foot ulcers. 1, 4

Critical Considerations:

  • Fragmentation risk in pathology specimens: When used to mount prostate core biopsies, Telfa significantly increases specimen fragmentation (46% fragmentation rate with 3 cores per jar versus 19% unmounted, p = 0.01), which can compromise diagnostic accuracy 7
  • Telfa fibers can be difficult to remove completely from wounds, potentially requiring careful attention during dressing changes 3
  • For chronic wounds, dressing selection should prioritize exudate management and patient comfort over any perceived antimicrobial or healing-enhancement properties 1, 4

Proper Application Technique

  • Apply Telfa directly to the wound surface as a primary dressing layer 1
  • May require a secondary absorbent dressing (such as foam or burn dressing) to collect excess exudate 1
  • In severe burns or extensive skin loss, position the non-adherent layer widely to prevent adhesions between exposed tissue and surrounding structures 1
  • Change dressings based on exudate saturation rather than a fixed schedule 3

Role in Comprehensive Wound Management

Telfa is a component of wound care, not a standalone treatment—address underlying causes of delayed healing such as pressure, infection, or poor perfusion. 4

  • For infected wounds, systemic antibiotics are indicated rather than relying on antimicrobial dressing properties 4
  • Wounds failing to improve after 2-4 weeks require reassessment and treatment modification 8
  • Combine with appropriate wound cleansing, debridement, and pressure offloading as clinically indicated 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Wound care following CO2 laser resurfacing using Kaltostat, Duoderm, and Telfa for dressings.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2000

Guideline

Wound Care Regimen with Gray Mepilex Dressing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dressing the part.

Dermatologic clinics, 1998

Guideline

Cadexomer Iodine Powder for Chronic Wound Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.